We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWKS icon
326
Skyworks Solutions
SWKS
$9.06B
$14.9M 0.06%
164,458
-40,897
-20% -$3.83M
RSP icon
327
Invesco S&P 500 Equal Weight ETF
RSP
$96.3B
$14.8M 0.06%
+138,713
New +$14.7M
GE icon
328
GE Aerospace
GE
$367B
$14.7M 0.06%
271,890
-33,896
-11% -$2.09M
PFG icon
329
Principal Financial Group
PFG
$23.6B
$13.5M 0.05%
230,569
-4,697
-2% -$262K
PM icon
330
Philip Morris
PM
$301B
$13.4M 0.05%
164,619
-5,664
-3% -$465K
LAMR icon
331
Lamar Advertising Co
LAMR
$16.2B
$13.3M 0.05%
170,410
-4,366
-2% -$325K
YUM icon
332
Yum! Brands
YUM
$41B
$13.1M 0.05%
144,414
-5,407
-4% -$451K
DXC icon
333
DXC Technology
DXC
$1.63B
$13.1M 0.05%
139,830
-1,166
-0.8% -$103K
TRV icon
334
Travelers Companies
TRV
$80.8B
$13.1M 0.05%
100,661
-11,870
-11% -$1.53M
HRL icon
335
Hormel Foods
HRL
$13.9B
$13.1M 0.05%
331,268
-7,129
-2% -$273K
ORLY icon
336
O'Reilly Automotive
ORLY
$72.4B
$12.7M 0.05%
550,020
-1,243,890
-69% -$26.4M
NSC icon
337
Norfolk Southern
NSC
$78.8B
$12.6M 0.05%
69,717
+2,486
+4% +$425K
ULTA icon
338
Ulta Beauty
ULTA
$20.4B
$12.4M 0.05%
44,050
-8,243
-16% -$2.1M
TFC icon
339
Truist Financial
TFC
$63.2B
$12.4M 0.05%
255,454
-3,052
-1% -$157K
UPM
340
DELISTED
UPM-KYMMRME ADR (REPR ORD SHS)
UPM
$12.3M 0.05%
314,360
+3,235
+1% +$127K
ALGN icon
341
Align Technology
ALGN
$12B
$12.1M 0.05%
30,832
-648
-2% -$239K
NVO
342
Novo Nordisk
NVO
$216B
$12.1M 0.05%
511,300
+148,774
+41% +$3.63M
TMO icon
343
Thermo Fisher Scientific
TMO
$211B
$11.9M 0.05%
48,640
-191,413
-80% -$44M
SONY icon
344
Sony
SONY
$123B
$11.6M 0.05%
959,455
+8,845
+0.9% +$97.4K
CMI icon
345
Cummins
CMI
$91.7B
$11.6M 0.05%
79,657
-25,827
-24% -$3.64M
AVGO icon
346
Broadcom
AVGO
$1.82T
$11.4M 0.05%
462,110
-5,260
-1% -$118K
OXY icon
347
Occidental Petroleum
OXY
$57B
$11M 0.04%
133,391
+2,409
+2% +$195K
HBI
348
DELISTED
Hanesbrands
HBI
$10.9M 0.04%
593,643
-81,105
-12% -$1.57M
AEP icon
349
American Electric Power
AEP
$73.7B
$10.8M 0.04%
151,748
-6,048
-4% -$430K
HAS icon
350
Hasbro
HAS
$12.6B
$10.6M 0.04%
100,917
-897
-0.9% -$89.8K

Similar funds

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.